Rallybio
Price & Volume
Stats
See more52W Range | $0.22-$1.24 |
Market Cap | $27.1M |
Shares Short | 174,572 |
Financials
See moreRevenue (12 Mos) | $674,000 |
Revenue Growth (YoY) | -29.1% |
Gross Profit (12 Mos) | -$38.3M |
Diluted EPS | -$0.32 |
News
See moreYahoo Finance • 20 days ago
After-Hours Biotech Watch: IFRX, ABCL, RLYB Among Notable Risers
Yahoo Finance • 2 months ago
After-Hours Movers: Biotech And Medtech Stocks Jump On Volume And News
Yahoo Finance • 4 months ago
Recursion Reports Second Quarter 2025 Financial Results and Provides Business Update
Yahoo Finance • 5 months ago
Rallybio to sell interest in REV102 to Recursion Pharmaceuticals for up to $25M
About
CEO | Dr. Stephen Uden M.B, M.D. |
CFO | Mr. Jonathan I. Lieber M.B.A. |
Address | 234 Church Street, New Haven, CT, United States, 06510 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 15 |
